Thus, the targets regulating the expression of TGF-β, TGF-βR1 and p53 or the phosphorylation level of SMAD3 in the TGF-β signaling pathway have yet to be explained, and will increase our understanding and provide novel tools for diagnosis and treatment of metastatic PCa. The gene discussed is SMAD3; the disease is posterior cortical atrophy.